BofA lowered the firm’s price target on Corpay to $310 from $331 and keeps a Buy rating on the shares. Corpay’s Q2 results were “fine,” but core guidance is weaker as it now includes Paymerang benefit, the analyst tells investors in a post-earnings note. After the report, the firm adjusted estimates and lowered its multiple to account for lower market and peer multiples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPAY:
- Corpay price target raised to $350 from $295 at Jefferies
- Corpay price target raised to $330 from $326 at JPMorgan
- Uber, Birkenstock among additions to Deutsche Bank ‘Fresh Money List’ for Q3
- Corpay price target lowered to $330 from $350 at Barclays
- Corpay price target raised to $331 from $326 at BofA